Colgate-Palmolive sees "extraordinary losses" over devaluation in Venezuela
The company expects earnings per share to drop some USD 5-7 cents per quarter in 2013, because of the conversion of its financial statements to the new Venezuelan exchange rate
Multinational company Colgate-Palmolive said Monday that due to the devaluation of the Venezuelan currency, it will record extraordinary losses at USD 120 million, or USD 25 cents per share, in the first quarter of 2013.
Colgate expects a reduction in its earnings per share of some USD 5-7 cents per quarter in 2013, because of the conversion of the financial statements to the new Venezuelan exchange rate.
However, the devaluation will have no impact on the company's results or financial position in 2012, said the New York-based firm, according to Reuters.
Venezuela represents 5 percent of the total sales of Colgate.
From January 1, 2010, Colgate designated Venezuela as a hyperinflationary market and since then all the currency fluctuations are recorded in the income of the firm, the company said.
Monday's announcement comes after Colgate reported disappointing results in the fourth quarter in Latin America, mostly due to significant economic and labor problems in Venezuela.
An economic environment increasingly complicated in the Caribbean country hit both the turnover and gross profit of the company in the fourth quarter. The firm faced labor slowdown in its Venezuelan plant during the last quarter of 2012.
Dossier
Chapo's drug traffic network
Luis Jiménez Alfaro seems to have hidden under the rocks. The last time he was seen was on April 2006 walking calmly around Simón Bolívar International Airport of Maiquetía, located nearby Caracas. At that time, more than five tons of cocaine arrived in Mexico in an airplane which took off from Venezuela, and his name featured as a missing piece of the puzzle of one of the most massive drug shipments that has been witnessed in the Western Hemisphere.
- Read
Cómo anunciar |
Suscripciones |
Contáctenos |
Política de privacidad
Términos legales |
Condiciones de uso |
Mapa del Sitio |
Ayuda
El Universal - Todos los derechos reservados 2013